Re-Launch of UK’s Innovative Licensing and Access Pathway (“ILAP”)
MHRA Consultation on Individualised mRNA Cancer Immunotherapies – Unique opportunity for a streamlined risk based regulatory framework?
European Commission Consults on Update to Pharmacovigilance Rules
Are you Windsor Framework ready? A focus on pharmaceutical supply chains and promotional material
MHRA Consults on New UK Pre-Market Medical Device Measures
UK’s Medical Device Post-market Surveillance Statutory Instrument Laid Before Parliament – What are the Key Changes for Medical Device Regulation?
UK’s Medical Device Post-market Surveillance Statutory Instrument Laid Before Parliament – What are the Key Changes for Medical Device Regulation?
New ABPI Code and PMCPA Constitution and Procedure Published
